Colonic metabolites of berry polyphenols: The missing link to biological activity?

British Journal of Nutrition

Volumn 104, Issue SUPPL.3, 2010, Pages

  Williamson, Gary ^a   Clifford, Michael N ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Anthocyanins; Berry; Blackcurrant; Chlorogenic acids; Flavonoids; Gut microflora; Phenylacetic acid; Phenylpropionic acid; Protocatechuic acid

Indexed keywords

3 (3' HYDROXYPHENYL)PROPIONIC ACID; ANTHOCYANIN; BENZOIC ACID; COUMARIC ACID; CYANIDIN 3 O GLUCOSIDE; DIHYDROCAFFEIC ACID; DIHYDROFERULIC ACID; PHENYLACETIC ACID; PHENYLPROPIONIC ACID; PHENYLPROPRIONIC ACID; PHENYLVALERATE DERIVATIVE; POLYPHENOL DERIVATIVE; PREBIOTIC AGENT; PROCYANIDIN; PROTOCATECHUIC ACID; UNCLASSIFIED DRUG; FLAVONOID; PHENOL DERIVATIVE; PLANT EXTRACT; POLYPHENOLS;

BERRY; BIOTRANSFORMATION; BLACKCURRANT; CATABOLISM; CATABOLITE; DEHYDROXYLATION; DEMETHYLATION; DRUG ACTIVITY; FOOD INTAKE; HUMAN; HYDROXYLATION; IN VIVO STUDY; INTESTINE ABSORPTION; METABOLITE; MICROBIAL METABOLISM; NONHUMAN; REVIEW; SMALL INTESTINE; ANIMAL; CHEMISTRY; COLON; DIET; FRUIT; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY;

ANIMALS; BIOTRANSFORMATION; COLON; DIET; FLAVONOIDS; FRUIT; GASTROINTESTINAL TRACT; HUMANS; PHENOLS; PLANT EXTRACTS;

EID: 78049432112     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510003946     Document Type: Review

References (267)

1. Hooper L, Kroon PA, Rimm EB, et al. (2008) Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials. Am J Clin Nutr 88, 38-50.
2. Williamson G & Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81, 243S-255S.
3. Scholz S & Williamson G (2007) Interactions affecting the bioavailability of dietary polyphenols in vivo. Int J Vitam Nutr Res 77, 224-235.
4. Vitaglione P, Donnarumma G, Napolitano A, et al. (2007) Protocatechuic acid is the major human metabolite of cyanidin- glucosides. J Nutr 137, 2043-2048.
5. Nurmi T, Mursu J, Heinonen M, et al. (2009) Metabolism of berry anthocyanins to phenolic acids in humans. J Agric Food Chem 57, 2274-2281.
6. Jensen GS, Wu X, Patterson KM, et al. (2008) In vitro and in vivo antioxidant and anti-inflammatory capacities of an antioxidant-rich fruit and berry juice blend. Results of a pilot and randomized, double-blinded, placebo-controlled, crossover study. J Agric Food Chem 56, 8326-8333.
7. Crozier A, Jaganath IB & Clifford MN (2009) Dietary phenolics: Chemistry, bioavailability and effects on health. Nat Prod Rep 26, 1001-1043.
8. Crozier A, Clifford MN & Ashihara H (2006) Plant Secondary Metabolites. Occurrence, Structure and Role in the Human Diet. Oxford: Blackwell.
9. Bäckhed F, Ley RE, Sonnenburg JL, et al. (2005) Hostbacterial mutualism in the human intestine. Science 307, 1915-1920.
10. Savage DC (1977) Microbial ecology of the gastrointestinal tract. Ann Rev Microbiol 31, 107-133.
11. Salminen S, Isolauri E & Salminen E (1996) Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and future challenges. Antonie Van Leeuwenhoek 70, 347-358.
12. Tuohy K & Gibson GR (2006) Functions of the human intestinal flora: The use of probiotics and prebiotics. In Plant Secondary Metabolites. Occurrence, Structure and Role in the Human Diet, pp. 174-207 [A Crozier, MN Clifford and H Ashihara, editors]. Oxford: Blackwell.
13. Gill SR, Pop M, Deboy RT, et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science 312, 1355-1359.
14. Gronlund MM, Lehtonen OP, Eerola E, et al. (1999) Fecal microflora in healthy infants born by different methods of delivery: Permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 28, 19-25.
15. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, et al. (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30, 61-67.
16. Conway PL (2009) Microbial ecology of the human large intestine. In Human Colonic Bacteria-Role in Nutrition, Physiology and Pathology, [GR Gibson and GT Macfarlane, editors]. Boca Raton, FL: CRC Press.
17. Eckburg PB, Bik EM, Bernstein CN, et al. (2005) Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
18. Mueller S, Saunier K, Hanisch C, et al. (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: A cross-sectional study. Appl Environ Microbiol 72, 1027-1033.
19. Phipps AN, Stewart J, Wright B, et al. (1998) Effect of diet on the urinary excretion of hippuric acid and other dietaryderived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 28, 527-537.
20. Wang XL, Hur HG, Lee JH, et al. (2005) Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium. Appl Environ Microbiol 71, 214-219.
21. Raimondi S, Roncaglia L, De Lucia M, et al. (2009) Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Appl Microbiol Biotechnol 81, 943-950.
22. Knaup B, Kahle K, Erk T, et al. (2007) Human intestinal hydrolysis of phenol glycosides - a study with quercetin and p-nitrophenol glycosides using ileostomy fluid. Mol Nutr Food Res 51, 1423-1429.
23. Aura AM, Martin-Lopez P, O'Leary KA, et al. (2005) In vitro metabolism of anthocyanins by human gut microflora. Eur J Nutr 44, 133-142.
24. Keppler K & Humpf HU (2005) Metabolism of anthocyanins and their phenolic degradation products by the intestinal microflora. Bioorg Med Chem 13, 5195-5205.
25. Fleschhut J, Kratzer F, Rechkemmer G, et al. (2006) Stability and biotransformation of various dietary anthocyanins in vitro. Eur J Nutr 45, 7-18.
26. Braune A, Engst W & Blaut M (2005) Degradation of neohesperidin dihydrochalcone by human intestinal bacteria. J Agric Food Chem 53, 1782-1790.
27. Gonthier MP, Remesy C, Scalbert A, et al. (2006) Microbial metabolism of caffeic acid and its esters chlorogenic and caftaric acids by human faecal microbiota in vitro. Biomed Pharmacother 60, 536-540.
28. Labib S, Hummel S, Richling E, et al. (2006) Use of the pig caecum model to mimic the human intestinal metabolism of hispidulin and related compounds. Mol Nutr Food Res 50, 78-86.
29. Rafii F, Jackson LD, Ross I, et al. (2007) Metabolism of daidzein by fecal bacteria in rats. Comp Med 57, 282-286.
30. Forester SC & Waterhouse AL (2008) Identification of Cabernet Sauvignon anthocyanin gut microflora metabolites. J Agric Food Chem 56, 9299-9304.
31. Lee HC, Jenner AM, Low CS, et al. (2006) Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol 157, 876-884.
32. Tzounis X, Vulevic J, Kuhnle GG, et al. (2008) Flavanol monomer-induced changes to the human faecal microflora. Br J Nutr 99, 782-792.
33. Gao K, Xu A, Krul C, et al. (2006) Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity. J Nutr 136, 52-57.
34. Peppercorn MA & Goldman P (1972) Caffeic acid metabolism by gnotobiotic rats and their intestinal bacteria. Proc Natl Acad Sci U S A 69, 1413-1415.
35. Hooper LV & Gordon JI (2001) Commensal host-bacterial relationships in the gut. Science 292, 1115-1118.
36. Stoupi S, Williamson G, Drynan JW, et al. (2010) A comparison of the in vitro biotransformation of (2)-epicatechin and procyanidin B2 by human faecal microbiota. Mol Nutr Food Res 54, 747-759.
37. He J, Magnuson BA & Giusti MM (2005) Analysis of anthocyanins in rat intestinal contents - impact of anthocyanin chemical structure on fecal excretion. J Agric Food Chem 53, 2859-2866.
38. Scheline RR & Midtvedt T (1970) Absence of dehydroxylation of caffeic acid in germ-free rats. Experientia 26, 1068-1069.
39. Tamura M & Saitoh H (2006) Comparison of the in vitro metabolism of isoflavones by fecal flora from human floraassociated mice and human. J Sci Food Agric 86, 1567-1570. (Pubitemid 44086017)
40. Rumney CJ & Rowland IR (1992) In vivo and in vitro models of the human colonic flora. CRC Crit Rev Food Sci Nutr 31, 299-331.
41. de Eds F (1968) Flavonoid metabolism. In Metabolism of Cyclic Compounds, pp. 127-192 [M Florkin and EH Stotz, editors]. London: Elsevier.
42. Griffiths LA (1982) Mammalian metabolism of flavonoids. In The Flavonoids: Advances in Research, pp. 681-718 [JB Harborne and TJ Mabry, editors]. London: Chapman & Hall.
43. Berry DF, Francis AJ & Bollag J-M (1987) Microbial metabolism of homocyclic and heterocyclic aromatic compounds under anaerobic conditions. Microbiol Rev 51, 43-59.
44. Knust U, Erben G, Spiegelhalder B, et al. (2006) Identification and quantitation of phenolic compounds in faecal matrix by capillary gas chromatography and nano-electrospray mass spectrometry. Rapid Commun Mass Spectrom 20, 3119-3129.
45. Jenner AM, Rafter J & Halliwell B (2005) Human fecal water content of phenolics: The extent of colonic exposure to aromatic compounds. Free Radic Biol Med 38, 763-772.
46. Hattori M, Shu YZ, El Sedawy AI, et al. (1988) Metabolism of homoorientin by human intestinal bacteria. J Nat Prod 51, 874-878.
47. Daniel EM, Ratnayake S, Kinstle T, et al. (1991) The effects of pH and rat intestinal contents on the liberation of ellagic acid from purified and crude ellagitannins. J Nat Prod 54, 946-952.
48. Kim DH, Kang HJ, Park SH, et al. (1994) Characterization of b-glucosidase and b-glucuronidase of alkalotolerant intestinal bacteria. Biol Pharm Bull 17, 423-426.
49. Kroon PA, Faulds CB, Ryden P, et al. (1996) Release of covalently bound ferulic acid from fiber in the human colon. J Agric Food Chem 45, 661-667.
50. Goodwin BL, Ruthven CRJ & Sandler M (1994) Gut flora and the origin of some urinary aromatic phenolic compounds. Biochem Pharmacol 47, 2294-2297.
51. Adamson RH, Bridges JW, Evans ME, et al. (1970) Species differences in the aromatization of quinic acid in vivo and the role of gut bacteria. Biochem J 116, 437-443.
52. Walle T, Walle UK & Halushka PV (2001) Carbon dioxide is the major metabolite of quercetin in humans. J Nutr 131, 2648-2652.
53. Das NP & Griffiths LA (1969) Studies on flavonoid metabolism. Metabolism of (+)-[14C]catechin in the rat and guinea pig. Biochem J 115, 831-836.
54. Griffiths LA & Smith GE (1972) Metabolism of myricetin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro. Biochem J 130, 141-151.
55. Smith GE & Griffiths LA (1970) Metabolism of myricitrin and 3,4,5-trihydroxyphenylacetic acid. Biochem J 118, 53P-54P.
56. Griffiths LA & Smith GE (1972) Metabolism of apigenin and related compounds in the rat. Biochem J 128, 901-911.
57. Curtius HC, Mettler M & Ettlinger L (1976) Study of the intestinal tyrosine metabolism using stable isotopes and gas chromatography- mass spectrometry. J Chromatogr 126, 569-580.
58. Fuchs-Mettler M, Curtius HC, Baerlocher K, et al. (1980) A new rearrangement reaction in tyrosine metabolism. Eur J Biochem 108, 527-534.
59. 14C]cyanidanol-3) and its metabolite, 30-O-methyl-(+)- catechin. Xenobiotica 17, 423-434.
60. Blaut M, Schoefer L & Braune A (2003) Transformation of flavonoids by intestinal microorganisms. Int J Vitam Nutr Res 73, 79-87.
61. Hackett AM & Griffiths LA (1981) The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat, mouse, and marmoset. Drug Metab Dispos 9, 54-59.
62. Hackett AM, Griffiths LA & Wermeille M (1985) The quantitative disposition of 3-O-methyl-(+)-U-[-14C]catechin in man following oral administration. Xenobiotica 15, 907-914.
63. Krumholz LR & Bryant MP (1988) Characterization of the pyrogallol-phloroglucinol isomerase of Eubacterium oxidoreducens. J Bact 170, 2472-2479.
64. Krumholz LR, Crawford RL, Hemling ME, et al. (1987) Metabolism of gallate and phloroglucinol in Eubacterium oxidoreducens via 3-hydroxy-5-oxohexanoate. J Bact 169, 1886-1890.
65. Haddock JD & Ferry JG (1993) Initial steps in the anaerobic degradation of 3,4,5-trihydroxybenzoate by Eubacterium oxidoreducens: Characterization of mutants and role of 1,2,3,5-tetrahydroxybenzene. J Bacteriol 175, 669-673.
66. Haddock JD & Ferry JG (1989) Purification and properties of phloroglucinol reductase from Eubacterium oxidoreducens G-41. J Biol Chem 264, 4423-4427.
67. Jeffrey AM, Jerina DM, Self R, et al. (1972) The bacterial degradation of flavonoids. Oxidative fission of the A-ring of dihydrogossypetin by a Pseudomonas sp. Biochem J 130, 383-390.
68. Jeffrey AM, Knight M & Evans WC (1972) The bacterial degradation of flavonoids. Hydroxylation of the A-ring of taxifolin by a soil pseudomonad. Biochem J 130, 373-381.
69. Simmering R, Kleessen B & Blaut M (1999) Quantification of the flavonoid-degrading bacterium Eubacterium ramulus in human fecal samples with a species-specific oligonucleotide hybridization probe. Appl Environ Microbiol 65, 3705-3709.
70. Simmering R, Pforte H, Jacobasch G, et al. (2002) The growth of the flavonoid-degrading intestinal bacterium Eubacterium ramulus, is stimulated by dietary flavonoids in vivo. FEMS Microbiol Ecol 40, 243-248.
71. Schneider H & Blaut M (2000) Anaerobic degradation of flavonoids by Eubacterium ramulus. Arch Microbiol 173, 71-75.
72. Schneider H, Schwiertz A, Collins MD, et al. (1999) Anaerobic transformation of quercetin-3-glucoside by bacteria from the human intestinal tract. Arch Microbiol 171, 81-91.
73. Schneider H, Simmering R, Hartmann L, et al. (2000) Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria. J Appl Microbiol 89, 1027-1037.
74. Schoefer L, Mohan R, Braune A, et al. (2002) Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett 208, 197-202.
75. Schoefer L, Braune A & Blaut M (2004) Cloning and expression of a phloretin hydrolase gene from Eubacterium ramulus and characterization of the recombinant enzyme. Appl Environ Microbiol 70, 6131-6137.
76. Herles C, Braune A & Blaut M (2004) First bacterial chalcone isomerase isolated from Eubacterium ramulus. Arch Microbiol 181, 428-434.
77. Clifford MN (2000) Anthocyanins - nature, occurrence and dietary burden. J Sci Food Agric 80, 1063-1072.
78. Hur H & Rafii F (2000) Biotransformation of the isoflavonoids biochanin A, formononetin, and glycitein by Eubacterium limosum. FEMS Microbiol Lett 192, 21-25.
79. Kim DH, Konishi L & Kobashi K (1986) Purification, characterization and reaction mechanism of novel arylsulfotransferase obtained from an anaerobic bacterium of human intestine. Biochim Biophys Acta 872, 33-41.
80. Wang LQ, Meselhy MR, Li Y, et al. (2000) Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Chem Pharm Bull 48, 1606-1610.
81. Wang LQ, Meselhy MR, Li Y, et al. (2001) The heterocyclic ring fission and dehydroxylation of catechins and related compounds by Eubacterium sp. strain SDG-2, a human intestinal bacterium. Chem Pharm Bull 49, 1640-1643.
82. Winter J, Moore LH, Dowell VR, et al. (1989) C-ring cleavage of flavonoids by human intestinal bacteria. Appl Environ Microbiol 55, 1203-1208.
83. Winter J, Popoff MR, Grimont P, et al. (1991) Clostridium orbiscindens sp. nova., human intestinal bacterium capable of cleaving the flavonoid C-ring. Int J Syst Bacteriol 41, 355-357.
84. Jang IS & Kim DH (1996) Purification and characterization of alpha-L-rhamnosidase from Bacteroides JY-6, a human intestinal bacterium. Biol Pharm Bull 19, 1546-1549.
85. Bokkenheuser VD, Shackleton CH & Winter J (1987) Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem J 248, 953-956.
86. Kim D-H, Sohng IS, Kobashi K, et al. (1996) Purification and characterization of b-glucosidase from Bacteroides JY-6, a human intestinal bacterium. Biol Pharm Bull 19, 1121-1125.
87. Kim DH, Kim SY, Park SY, et al. (1999) Metabolism of quercitrin by human intestinal bacteria and its relation to some biological activities. Biol Pharm Bull 22, 749-751.
88. Sung CK, Kang GH, Yoon SS, et al. (1996) Glycosidases that convert natural glycosides to bioactive compounds. Adv Exp Med Biol 404, 23-36.
89. Justesen U, Arrigoni E, Larsen BR, et al. (2000) Degradation of flavonoid glycosides and aglycones during in vitro fermentation with human faecal flora. Lebensmittel Wissenschaft Technol 33, 424-430.
90. Kim DH, Jung EA, Sohng IS, et al. (1998) Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res 21, 17-23.
91. Kay CD, Kroon PA & Cassidy A (2009) The bioactivity of dietary anthocyanins is likely to be mediated by their degradation products. Mol Nutr Food Res 53, Suppl. 1, S92-101.
92. Peppercorn MA & Goldman P (1971) Caffeic acid metabolism by bacteria of the human gastrointestinal tract. J Bact 108, 996-1000.
93. Indahl SR & Scheline RR (1968) Decarboxylation of 4-hydroxycinnamic acids by Bacillus strains isolated from rat intestine. Appl Microbiol 16, 667.
94. Groenewoud G & Hundt HKL (1984) The microbial metabolism of (+)-catechins to two novel diarylpropan-2-ol metabolites in vitro. Xenobiotica 14, 711-717.
95. Meselhy MR, Nakamura N & Hattori M (1997) Biotransformation of (2)-epicatechin 3-O-gallate by human intestinal bacteria. Chem Pharm Bull 45, 888-893.
96. Doyle B & Griffiths LA (1980) The metabolism of ellagic acid in the rat. Xenobiotica 10, 247-256.
97. Cerda B, Llorach R, Ceron JJ, et al. (2003) Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur J Nutr 42, 18-28.
98. Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, et al. (2006) Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 54, 1611-1620.
99. Seeram NP, Aronson WJ, Zhang Y, et al. (2007) Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem 55, 7732-7737.
100. Day AJ, Canada FJ, Díaz JC, et al. (2000) Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 468, 166-170.
101. Hollman PCH, Buijsman MNCP, van Gameren Y, et al. (1999) The sugar moiety is a major determinant of the absorption of the dietary flavonoid glycosides in man. Free Radic Res 31, 569-573.
102. Walle T, Otake Y, Walle UK, et al. (2000) Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. J Nutr 130, 2658-2661.
103. Hollman PCH, de Vries JHM, van Leeuwen SD, et al. (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 62, 1276-1282.
104. Olthof MR, Hollman PC, Buijsman MN, et al. (2003) Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr 133, 1806-1814.
105. Auger C, Mullen W, Hara Y, et al. (2008) Bioavailability of polyphenon E flavan-3-ols in humans with an ileostomy. J Nutr 138, 1535S-1542S.
106. Kahle K, Kraus M, Scheppach W, et al. (2005) Colonic availability of apple polyphenols - a study in ileostomy subjects. Mol Nutr Food Res 49, 1143-1150.
107. Kahle K, Kraus M, Scheppach W, et al. (2006) Studies on apple and blueberry fruit constituents: Do the polyphenols reach the colon after ingestion? Mol Nutr Food Res 50, 418-423.
108. Marks SC, Mullen W, Borges G, et al. (2009) Absorption, metabolism, and excretion of cider dihydrochalcones in healthy humans and subjects with an ileostomy. J Agric Food Chem 57, 2009-2015.
109. Poquet L, Clifford MN & Williamson G (2008) Transport and metabolism of ferulic acid through the colonic epithelium. Drug Metab Dispos 36, 190-197.
110. Hayeshi R, Hilgendorf C, Artursson P, et al. (2008) Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. Eur J Pharm Sci 35, 383-396.
111. Gutmann H, Fricker G, Torok M, et al. (1999) Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake. Pharm Res 16, 402-407.
112. Sambuy Y, De Angelis I, Ranaldi G, et al. (2005) The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21, 1-26.
113. Lindsay DG & Clifford MN (2000) Special issue devoted to critical reviews produced within the EU Concerted Action 'Nutritional Enhancement of Plant-based Food in European Trade' (NEODIET). J Sci Food Agric 80, 793-1137.
114. Crozier A, Jaganath IB & Clifford MN (2006) Phenols, polyphenols and tannins: An overview. In Plant Secondary Metabolites. Occurrence, Structure and Role in the Human Diet, pp. 1-24 [A Crozier, MN Clifford and H Ashihara, editors]. Oxford: Blackwell.
115. Crozier A, Yokota T, Jaganath IB, et al. (2006) Secondary metabolites in fruits, vegetables, beverages and other plantbased dietary components. In Plant Secondary Metabolites. Occurrence, Structure and Role in the Human Diet, pp. 208-302 [A Crozier, MN Clifford and H Ashihara, editors]. Oxford: Blackwell.
116. Maatta KR, Kamal-Eldin A & Torronen AR (2003) Highperformance liquid chromatography (HPLC) analysis of phenolic compounds in berries with diode array and electrospray ionization mass spectrometric (MS) detection: Ribes species. J Agric Food Chem 51, 6736-6744.
117. Gu L, Kelm MA, Hammerstone JF, et al. (2004) Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 134, 613-617.
118. Hodgson JM, Morton LW, Puddey IB, et al. (2000) Gallic acid metabolites are markers of black tea intake in humans. J Agric Food Chem 48, 2276-2280.
119. Shahrzad S & Bitsch I (1998) Determination of gallic acid and its metabolites in human plasma and urine by highperformance liquid chromatography. J Chrom B Biomed Sci Appl 705, 87-95.
120. Matsumoto H, Inaba H, Kishi M, et al. (2001) Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J Agric Food Chem 49, 1546-1551.
121. Matsumoto H, Ito K, Yonekura K, et al. (2007) Enhanced absorption of anthocyanins after oral administration of phytic acid in rats and humans. J Agric Food Chem 55, 2489-2496.
122. Felgines C, Talavera S, Gonthier MP, et al. (2003) Strawberry anthocyanins are recovered in urine as glucuro- and sulfoconjugates in humans. J Nutr 133, 1296-1301.
123. Mullen W, Edwards CA, Serafini M, et al. (2008) Bioavailability of pelargonidin-3-O-glucoside and its metabolites in humans following the ingestion of strawberries with and without cream. J Agric Food Chem 56, 713-719.
124. Tsuda T, Horio F & Osawa T (1999) Absorption and metabolism of cyanidin 3-O-b-D-glucoside in rats. FEBS Lett 449, 179-182.
125. Wu X, PittmanIii HE, Hager T, et al. (2009) Phenolic acids in black raspberry and in the gastrointestinal tract of pigs following ingestion of black raspberry. Mol Nutr Food Res 53, Suppl. 1, S76-S84.
126. Russell WR, Scobbie L, Labat A, et al. (2009) Selective bio-availability of phenolic acids from Scottish strawberries. Mol Nutr Food Res 53, Suppl. 1, S85-S91.
127. Hollands W, Brett GM, Dainty JR, et al. (2008) Urinary excretion of strawberry anthocyanins is dose dependent for physiological oral doses of fresh fruit. Mol Nutr Food Res 52, 1097-1105.
128. Stohr H & Herrmann K (1975) The phenolics of strawberries and their changes during development and ripeness of the fruits. Z Lebensm Unters -Forsch 158, 341-348.
129. Ichiyanagi T, Kashiwada Y, Ikeshiro Y, et al. (2004) Complete assignment of bilberry (Vaccinium myrtillus L.) anthocyanins separated by capillary zone electrophoresis. Chem Pharm Bull (Tokyo) 52, 226-229.
130. Katsube N, Iwashita K, Tsushida T, et al. (2003) Induction of apoptosis in cancer cells by bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem 51, 68-75.
131. Ichiyanagi T, Hatano Y, Matsugo S, et al. (2004) Structural dependence of HPLC separation pattern of anthocyanins from Bilberry (Vaccinium myrtillus L.). Chem Pharm Bull (Tokyo) 52, 628-630.
132. Ek S, Kartimo H, Mattila S, et al. (2006) Characterization of phenolic compounds from lingonberry (Vaccinium vitis-idaea). J Agric Food Chem 54, 9834-9842.
133. Gonthier MP, Donovan JL, Texier O, et al. (2003) Metabolism of dietary procyanidins in rats. Free Radic Biol Med 35, 837-844.
134. Stoupi S, Williamson G, Viton S, et al. (2010) In vivo bioavailability, absorption, excretion and pharmacokinetics of [14C]-procyanidin B2 in male rats. Drug Metab Dispos 38, 287-291.
135. Rios LY, Gonthier MP, Remesy C, et al. (2003) Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am J Clin Nutr 77, 912-918.
136. Stalmach A, Mullen W, Barron D, et al. (2009) Metabolite profiling of methyl, glucuronyl and sulfate conjugates in plasma and urine derived from chlorogenic acids following the ingestion of coffee by humans: Identification of biomarkers of coffee consumption. Drug Metab Dispos 37, 1749-1758.
137. Renouf M, Guy PA, Marmet C, et al. (2010) Measurement of caffeic and ferulic acid equivalents in plasma after coffee consumption: Small intestine and colon are key sites for coffee metabolism. Mol Nutr Food Res 54, 760-766.
138. Olthof MR, Hollman PCH & Katan MB (2001) Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131, 66-71.
139. Goldstein DS, Stull R, Markey SP, et al. (1984) Dihydrocaffeic acid: A common contaminant in the liquid chromatographicelectrochemical measurement of plasma catecholamines in man. J Chromatogr 311, 148-153.
140. Wittemer SM, Ploch M, Windeck T, et al. (2005) Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of artichoke leaf extracts in humans. Phytomed 12, 28-38.
141. Gonthier MP, Cheynier V, Donovan JL, et al. (2003) Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J Nutr 133, 461-467.
142. Gonthier MP, Verny MA, Besson C, et al. (2003) Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr 133, 1853-1859.
143. 14C] ferulic acid in the rat. Arch Int Physiol Biochim 79, 589-618.
144. Nutley BP, Farmer P & Caldwell J (1994) Metabolism of trans-cinnamic acid in the rat and the mouse and its variation with dose. Food Chem Toxicol 32, 877-886.
145. Haughton E, Clifford MN & Sharp P (2007) Monocarboxylate transporter expression is associated with the absorption of benzoic acid in human intestinal epithelial cells. J Sci Food Agric 87, 239-244.
146. Mori S, Takanaga H, Ohtsuki S, et al. (2003) Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J Cereb Blood Flow Metab 23, 432-440.
147. Cao YG, Zhang L, Ma C, et al. (2009) Metabolism of protocatechuic acid influences fatty acid oxidation in rat heart: New anti-angina mechanism implication. Biochem Pharmacol 77, 1096-1104.
148. Liu HX, Liu Y, Zhang JW, et al. (2008) UDP-glucuronosyltransferase 1A6 is the major isozyme responsible for protocatechuic aldehyde glucuronidation in human liver microsomes. Drug Metab Dispos 36, 1562-1569.
149. Panoutsopoulos GI & Beedham C (2005) Enzymatic oxidation of vanillin, isovanillin and protocatechuic aldehyde with freshly prepared Guinea pig liver slices. Cell Physiol Biochem 15, 89-98.
150. Tanaka T, Kawamori T, Ohnishi M, et al. (1994) Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and postinitiation phases. Cancer Res 54, 2359-2365. (Pubitemid 24138725)
151. Tanaka T, Kojima T, Kawamori T, et al. (1995) Chemoprevention of digestive organs carcinogenesis by natural product protocatechuic acid. Cancer 75, 1433-1439.
152. Tarozzi A, Morroni F, Hrelia S, et al. (2007) Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells. Neurosci Lett 424, 36-40.
153. Yip EC, Chan AS, Pang H, et al. (2006) Protocatechuic acid induces cell death in HepG2 hepatocellular carcinoma cells through a c-Jun N-terminal kinase-dependent mechanism. Cell Biol Toxicol 22, 293-302.
154. Wang H, Liu TQ, Guan S, et al. (2008) Protocatechuic acid from Alpinia oxyphylla promotes migration of human adipose tissue-derived stromal cells in vitro. Eur J Pharmacol 599, 24-31.
155. Guan S, Ge D, Liu TQ, et al. (2009) Protocatechuic acid promotes cell proliferation and reduces basal apoptosis in cultured neural stem cells. Toxicol In Vitro 23, 201-208.
156. Tamura A, Fukushima M, Shimada K, et al. (2004) Cholesterol metabolism in rat is affected by protocatechuic acid. J Nutr Sci Vitaminol (Tokyo) 50, 13-18.
157. Thompson P, Balis F, Serabe BM, et al. (2003) Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer. Cancer Chemother Pharmacol 52, 417-423.
158. Wajngot A, Chandramouli V, Schumann WC, et al. (2000) A probing dose of phenylacetate does not affect glucose production and gluconeogenesis in humans. Metabolism 49, 1211-1214.
159. Inoue O, Hosoi R, Momosaki S, et al. (2006) Evaluation of [14C]phenylacetate as a prototype tracer for the measurement of glial metabolism in the rat brain. Nucl Med Biol 33, 985-989.
160. Thibault A, Samid D, Cooper MR, et al. (1995) Phase I study of phenylacetate administered twice daily to patients with cancer. Cancer 75, 2932-2938.
161. James MO & Smith RL (2009) The conjugation of phenylacetic acid in phenylketonurics. Eur J Clin Pharmacol 5, 243-246.
162. Karlsson PC, Huss U, Jenner A, et al. (2005) Human fecal water inhibits COX-2 in colonic HT-29 cells: Role of phenolic compounds. J Nutr 135, 2343-2349.
163. MacArthur RB, Altincatal A & Tuchman M (2004) Pharmacokinetics of sodium phenylacetate and sodium benzoate following intravenous administration as both a bolus and continuous infusion to healthy adult volunteers. Mol Genet Metab 81, Suppl. 1, S67-S73.
164. Kang HL, Benzer S & Min KT (2002) Life extension in Drosophila by feeding a drug. Proc Natl Acad Sci U S A 99, 838-843.
165. Kasumov T, Brunengraber LL, Comte B, et al. (2004) New secondary metabolites of phenylbutyrate in humans and rats. Drug Metab Dispos 32, 10-19.
166. Li XN, Parikh S, Shu Q, et al. (2004) Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells. Clin Cancer Res 10, 1150-1159.
167. Franco OE, Onishi T, Umeda Y, et al. (2003) Phenylacetate inhibits growth and modulates cell cycle gene expression in renal cancer cell lines. Anticancer Res 23, 1637-1642.
168. Shibahara T, Onishi T, Franco OE, et al. (2005) Downregulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells. Anticancer Res 25, 1881-1888.
169. Clifford MN (2000) Chlorogenic acids and other cinnamates - nature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric 80, 1033-1042.
170. Clifford MN (1999) Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden. J Sci Food Agric 79, 362-372.
171. Fallingborg J (1999) Intraluminal pH of the human gastrointestinal tract. Dan Med Bull 46, 183-196.
172. Jovanovic SV, Steenken S, Tosic M, et al. (1994) Flavonoids as antioxidants. J Am Chem Soc 116, 4846-4851.
173. Poquet L, Clifford MN & Williamson G (2008) Investigation of the metabolic fate of dihydrocaffeic acid. Biochem Pharmacol 75, 1218-1229.
174. Konishi Y & Kobayashi S (2004) Microbial metabolites of ingested caffeic acid are absorbed by the monocarboxylic acid transporter (MCT) in intestinal Caco-2 cell monolayers. J Agric Food Chem 52, 6418-6424.
175. Konishi Y & Kobayashi S (2004) Transepithelial transport of chlorogenic acid, caffeic acid, and their colonic metabolites in intestinal caco-2 cell monolayers. J Agric Food Chem 52, 2518-2526.
176. Wong CC, Meinl W, Glatt H-R, et al. (2010) In vitro and in vivo conjugation of dietary hydroxycinnamic acids by UDP-glucuronosyltransferases and sulfotransferases in humans. J Nutr Biochem, (Epublication ahead of print version).
177. Poquet L, Clifford MN & Williamson G (2008) Effect of dihydrocaffeic acid on UV irradiation of human keratinocyte HaCaT cells. Arch Biochem Biophys 476, 196-204.
178. Larrosa M, Lodovici M, Morbidelli L, et al. (2008) Hydrocaffeic and p-coumaric acids, natural phenolic compounds, inhibit UV-B damage in WKD human conjunctival cells in vitro and rabbit eye in vivo. Free Radic Res 42, 903-910.
179. Guglielmi F, Luceri C, Giovannelli L, et al. (2003) Effect of 4-coumaric and 3,4-dihydroxybenzoic acid on oxidative DNA damage in rat colonic mucosa. Br J Nutr 89, 581-587.
180. Larrosa M, Luceri C, Vivoli E, et al. (2009) Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation
181. Bhat CS & Ramasarma T (1979) Effect of phenyl and phenolic acids on mevalonate-5-phosphate kinase and mevalonate-5- pyrophosphate decarboxylase of the rat brain. J Neurochem 32, 1531-1537. (Pubitemid 9163995)
182. Lee JS, Choi MS, Jeon SM, et al. (2001) Lipid-lowering and antioxidative activities of 3,4-di(OH)-cinnamate and 3,4- di(OH)-hydrocinnamate in cholesterol-fed rats. Clin Chim Acta 314, 221-229.
183. Yasuda T, Takasawa A, Nakazawa T, et al. (2003) Inhibitory effects of urinary metabolites on platelet aggregation after orally administering Shimotsu-To, a traditional Chinese medicine, to rats. J Pharm Pharmacol 55, 239-244.
184. Bok SH, Lee SH, Park YB, et al. (1999) Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methylglutaryl- CoA reductase and acyl CoA: Cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr 129, 1182-1185.
185. Kim HK, Jeong TS, Lee MK, et al. (2003) Lipid-lowering efficacy of hesperetin metabolites in high-cholesterol fed rats. Clin Chim Acta 327, 129-137.
186. Lee CH, Jeong TS, Choi YK, et al. (2001) Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun 284, 681-688.
187. Matsumoto N, Okushio K & Hara Y (1998) Effect of black tea polyphenols on plasma lipids in cholesterol-fed rats. J Nutr Sci Vitaminol 44, 337-342.
188. Yamakoshi J, Kataoka S, Koga T, et al. (1999) Proanthocyanidin- rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 142, 139-149.
189. Kurowska EM, Spence JD, Jordan J, et al. (2000) HDL-cholesterol- raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr 72, 1095-1100.
190. Mo H & Elson CE (2004) Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood) 229, 567-585.
191. Lee MJ, Maliakal P, Chen L, et al. (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (2)-epigallocatechin- 3-gallate by humans: Formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11, 1025-1032.
192. Sun CL, Yuan JM, Lee MJ, et al. (2002) Urinary tea polyphenols in relation to gastric and esophageal cancers: A prospective study of men in Shanghai, China. Carcinogen 23, 1497-1503.
193. Duweler KG & Rohdewald P (2000) Urinary metabolites of French maritime pine bark extract in humans. Pharmazie 55, 364-368.
194. Goto K, Kanaya S, Nishikawa T, et al. (1998) The influence of tea catechins on fecal flora of elderly residents in long-term care facilities. Ann Long-Term Care 6, 43-48.
195. Hara Y (1997) Influence of tea catechins on the digestive tract. J Cell Biochem 27, Suppl. 52-58.
196. Okubo T, Ishihara N, Oura A, et al. (1992) In vivo effect of tea polyphenol intake on human intestinal microflora and metabolism. Biosci Biotechnol Biochem 56, 588-591.
197. Min BR, Attwood GT, Reilly K, et al. (2002) Lotus corniculatus condensed tannins decrease in vivo populations of proteolytic bacteria and affect nitrogen metabolism in the rumen of sheep. Can J Microbiol 48, 911-921.
198. Ramos-Nino ME, Ramìrez-Rodriguez CA, Clifford MN, et al. (1997) A comparison of quantitative structure-activity relationships for the effect of benzoic and cinnamic acids on Listeria monocytogenes using multiple linear regression, artificial neural networks and fuzzy systems. J Appl Microbiol 82, 168-176.
199. Gargala G, Baishanbo A, Favennec L, et al. (2005) Inhibitory activities of epidermal growth factor receptor tyrosine kinasetargeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development. Antimicrob Agents Chemother 49, 4628-4634.
200. Kerboeuf D, Riou M & Guegnard F (2008) Flavonoids and related compounds in parasitic disease control. Mini Rev Med Chem 8, 116-128.
201. Li C, Lee M-J, Sheng S, et al. (2000) Stuctural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol 13, 177-184.
202. Clifford MN, Copeland EL, Bloxsidge JP, et al. (2000) Hippuric acid is a major excretion product associated with black tea consumption. Xenobiotica 30, 317-326.
203. Krumholz LR & Bryant MP (1986) Eubacterium oxidoreducens sp. nov. requiring H2 or formate to degrade gallate, pyrogallol, phloroglucinol and quercetin. 144, 8-14.
204. Booth AN & Williams RT (1963) Dehydroxylation of caffeic acid by rat and rabbit caecal contents and sheep rumen liquor. Nature 684-685.
205. Dayman J & Jepson JB (1969) The metabolism of caffeic acid in humans: The dehydroxylating action of intestinal bacteria. Biochem J 113, 11P.
206. Plumb GW, García-Conesa MT, Kroon PA, et al. (1999) Metabolism of chlorogenic acid by human plasma, liver, intestine and gut microflora. J Sci Food Agric 79, 390-392.
207. Couteau D, McCartney AL, Gibson GR, et al. (2001) Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J Appl Microbiol 90, 873-881.
208. Rechner AR, Smith MA, Kuhnle G, et al. (2004) Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products. Free Radic Biol Med 36, 212-225.
209. Gavaghan CL, Nicholson JK, Connor SC, et al. (2001) Directly coupled high-performance liquid chromatography and nuclear magnetic resonance spectroscopic with chemometric studies on metabolic variation in Sprague-Dawley rats. Anal Biochem 291, 245-252.
210. Stalmach A, Mullen W, Barron D, et al. (2009) Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: Identification of biomarkers of coffee consumption. Drug Metab Dispos 37, 1749-1758.
211. Kahle K, Huemmer W, Kempf M, et al. (2007) Polyphenols are intensively metabolized in the human gastrointestinal tract after apple juice consumption. J Agric Food Chem 55, 10605-10614.
212. Das NP (1969) Studies on flavonoid metabolism. Degradation of (+)-catechin by rat intestinal contents. Biochim Biophys Acta 177, 668-670.
213. Scheline RR (1970) The metabolism of (+)-catechin to hydroxyphenylvaleric acids by the intestinal microflora. Biochim Biophys Acta 222, 228-230.
214. Oshima Y & Watanabe H (1958) The mechanisms of catechin metabolism. 2. Neutral substances in the urine of rabbits administered (+)-catechin. J Biochem 45, 973-977.
215. Das NP & Griffiths LA (1968) Studies on flavonoid metabolism. Metabolism of (+)-catechin in the guinea pig. Biochem J 110, 449-456.
216. Das NP (1974) Studies on flavonoid metabolism. Excretion of m-hydroxyphenylhydracrylic acid from (+)-catechin in the monkey (Macaca iris sp.). Drug Metab Dispos 2, 209-213.
217. Griffiths LA & Barrow A (1964) Metabolism of flavonoid compounds in germ-free rats. Biochem J 92, 173-179.
218. Hattori S & Noguchi I (1959) Microbial degradation of rutin. Nature 184, 1145-1146.
219. Cheng KJ, Jones GA, Simpson FJ, et al. (1969) Isolation and identification of rumen bacteria capable of anaerobic rutin degradation. Can J Microbiol 15, 1365-1371.
220. Krishnamurty HG, Cheng KJ, Jones GA, et al. (1970) Identification of products produced by the anaerobic degradation of rutin and related flavonoids by Butyrivibrio sp. C3. Can J Microbiol 16, 759-767.
221. Baba S, Furuta T, Fujioka M, et al. (1983) Studies on drug metabolism by use of isotopes XXVII: Urinary metabolites of rutin in rats and the role of intestinal microflora in the metabolism of rutin. J Pharm Sci 72, 1155-1158.
222. Mullen W, Rouanet JM, Auger C, et al. (2008) Bioavailability of [2-14C]quercetin-40-glucoside in rats. J Agric Food Chem 56, 12127-12137.
223. Jaganath IB, Mullen W, Edwards CA, et al. (2006) The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man. Free Radic Res 40, 1035-1046.
224. Coldham NG, Darby C, Hows M, et al. (2002) Comparative metabolism of genistin by human and rat gut microflora: Detection and identification of the end-products of metabolism. Xenobiotica 32, 45-62.
225. Tsangalis D, Ashton JE, McGill AEJ, et al. (2002) Enzymic transformation of isoflavone phytoestrogens in soymilk by bglucosidase- producing Bifidobacteria. J Food Sci 67, 3104-3113.
226. Steer TE, Johnson IT, Gee JM, et al. (2003) Metabolism of the soybean isoflavone glycoside genistin in vitro by human gut bacteria and the effect of prebiotics. Br J Nutr 90, 635-642.
227. Atkinson C, Berman S, Humbert O, et al. (2004) In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J Nutr 134, 596-599.
228. Liang G, Zhang T, Wang J, et al. (2005) X-ray single-crystal analysis of (2)-(S)-equol isolated from rat's feces. Chem Biodivers 2, 959-963.
229. Simons AL, Renouf M, Hendrich S, et al. (2005) Metabolism of glycitein (7,40-dihydroxy-6-methoxy-isoflavone) by human gut microflora. J Agric Food Chem 53, 8519-8525.
230. Otieno DO, Ashton JF & Shah NP (2006) Evaluation of enzymic potential for biotransformation of isoflavone phytoestrogen in soymilk by Bifidobacterium animalis, Lactobacillus acidophilus and Lactobacillus casei. Food Res Int 39, 394-407.
231. Tamura M, Tsushida T & Shinohara K (2007) Isolation of an isoflavone-metabolizing, Clostridium-like bacterium, strain TM-40, from human faeces. Anaerobe 13, 32-35.
232. Bowey E, Adlercreutz H & Rowland I (2003) Metabolism of isoflavones and lignans by the gut microflora: A study in germ-free and human flora associated rats. Food Chem Toxicol 41, 631-636.
233. Kelly GE, Nelson C, Waring MA, et al. (1993) Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 223, 9-22.
234. Xu X, Harris KS, Wang HJ, et al. (1995) Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 125, 2307-2315.
235. Heinonen S, Wahala K & Adlercreutz H (1999) Identification of isoflavone metabolites dihydrodaidzein, dihydrogenistein, 60-OH-O-DMA, and cis-4-OH-equol in human urine by gas chromatography-mass spectroscopy using authentic reference compounds. Anal Biochem 274, 211-219.
236. Rowland IR, Wiseman H, Sanders TA, et al. (2000) Interindividual variation in metabolism of soy isoflavones and lignans: Influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36, 27-32.
237. Hoey L, Rowland IR, Lloyd AS, et al. (2004) Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children. Br J Nutr 91, 607-616.
238. Wiseman H, Casey K, Bowey EA, et al. (2004) Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 80, 692-699.
239. Walsh KR, Haak SJ, Bohn T, et al. (2007) Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies. Am J Clin Nutr 85, 1050-1056.
240. Cheng KJ, Krishnamurty HG, Jones GA, et al. (1971) Identification of products produced by the anaerobic degradation of naringin by Butyrivibrio sp. C3. Can J Microbiol 17, 129-131.
241. Yu KU, Jang IS, Kang KH, et al. (1997) Metabolism of Saikosaponin C and naringin by human intestinal bacteria. Arch Pharmacal Res 20, 420-424.
242. Possemiers S, Heyerick A, Robbens V, et al. (2005) Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin. J Agric Food Chem 53, 6281-6288.
243. Felgines C, Texier O, Morand C, et al. (2000) Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol Gastrointest Liver Physiol 279, G1148-G1154.
244. Roowi S, Mullen W, Edwards CA, et al. (2009) Yoghurt impacts on the excretion of phenolic acids derived from colonic breakdown of orange juice flavanones in humans. Mol Nutr Food Res 53, Suppl. 1, S68-S75.
245. Skjevrak I, Solheim E & Scheline RR (1986) Dihydrochalcone metabolism in the rat: Trihydroxylated derivatives related to phloretin. Xenobiotica 16, 35-45.
246. Borges G, Roowi S, Rouanet JM, et al. (2007) The bioavailability of raspberry anthocyanins and ellagitannins in rats. Mol Nutr Food Res 51, 714-725.
247. Groenewoud G & Hundt HKL (1986) The microbial metabolism of condensed (+)-catechins by rat caecal microflora. Xenobiotica 16, 99-107.
248. Deprez S, Brezillon C, Rabot S, et al. (2000) Polymeric proanthocyanidins are catabolized by human colonic microflora into lowmolecular- weight phenolic acids. J Nutr 130, 2733-2738.
249. Appeldoorn MA, Vincken JP, Aura MA, et al. (2009) Procyanidin dimers are metabolized by human microbiota with 2- (3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)- g-valerolactone as the major metabolites. J Agric Food Chem 57, 1084-1092.
250. Ward NC, Croft KD, Puddey IB, et al. (2004) Supplementation with grape seed polyphenols results in increased urinary excretion of 3- hydroxyphenylpropionic acid, an important metabolite of proanthocyanidins in humans. J Agric Food Chem 52, 5545-5549.
251. Rickard SE, Orcheson LJ, Seidl MM, et al. (1996) Dosedependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J Nutr 126, 2012-2019.
252. Heinonen S, Nurmi T, Liukkonen K, et al. (2001) In vitro metabolism of plant lignans: New precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49, 3178-3186.
253. Clavel T, Henderson G, Engst W, et al. (2006) Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol Ecol 55, 471-478.
254. Rickard SE & Thompson LU (1998) Chronic exposure to secoisolariciresinol diglycoside alters lignan disposition in rats. J Nutr 128, 615-623.
255. Glitso LV, Mazur WM, Adlercreutz H, et al. (2000) Intestinal metabolism of rye lignans in pigs. Br J Nutr 84, 429-437.
256. Nesbitt PD, Lam Y & Thompson LU (1999) Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr 69, 549-555.
257. Juntunen KS, Mazur WM, Liukkonen KH, et al. (2000) Consumption of wholemeal rye bread increases serum concentrations and urinary excretion of enterolactone compared with consumption of white wheat bread in healthy Finnish men and women. Br J Nutr 84, 839-846.
258. Mulder TP, Rietveld AG & van Amelsvoort JM (2005) Consumption of both black tea and green tea results in an increase in the excretion of hippuric acid into urine. Am J Clin Nutr 81, 256S-260S.
259. Griffiths LA (1970) 3,5-Dihydroxyphenylpropionic acid, a further metabolite of sinapic acid. Experientia 26, 723-724.
260. Kroon PA, Faulds CB, Ryden P, et al. (1996) Solubilisation of ferulic acid from plant cell wall materials in a model human gut system. Biochem Soc Trans 24, 384S.
261. Das NP & Sothy SP (1971) Studies on flavonoid metabolism. Biliary and urinary excretion of metabolites of (+)-(U-14C) catechin. Biochem J 125, 417-423.
262. Booth AN, Jones FT & DeEds F (1958) Metabolic fate of hesperidin, eriodictyol, homoeridictyol, and diosmin. J Biol Chem 230, 661-668.
263. Honohan T, Hale RL, Brown JP, et al. (1976) Synthesis and metabolic fate of hesperetin-3-14C. J Agric Food Chem 24, 906-911.
264. Scheline RR (1978) Mammalian Metabolism of Plant Xenobiotics. London: Academic Press.
265. Yasuda T, Inaba A, Ohmori M, et al. (2000) Urinary metabolites of gallic acid in rats and their radical-scavenging effects on 1,1-diphenyl-2- picrylhydrazyl radical. J Nat Prod 63, 1444-1446.
266. Muskiet FA & Groen A (1979) Urinary excretion of conjugated homovanillic acid, 3,4-dihydroxyphenylacetic acid, p-hydroxyphenylacetic acid, and vanillic acid by persons on their usual diet and patients with neuroblastoma. Clin Chem 25, 1281-1284.
267. Stalmach A, Steiling H, Williamson G, et al. (2010) Bioavailability of chlorogenic acids following acute ingestion of coffee by humans with an ileostomy. Arch Biochem Biophys 501, 98-105.